ATE239490T1 - Zusammensetzung enthaltend butyrospermum parkii extrakte und die verwendung als arzneimittel oder nahrungszusatz - Google Patents

Zusammensetzung enthaltend butyrospermum parkii extrakte und die verwendung als arzneimittel oder nahrungszusatz

Info

Publication number
ATE239490T1
ATE239490T1 AT00943697T AT00943697T ATE239490T1 AT E239490 T1 ATE239490 T1 AT E239490T1 AT 00943697 T AT00943697 T AT 00943697T AT 00943697 T AT00943697 T AT 00943697T AT E239490 T1 ATE239490 T1 AT E239490T1
Authority
AT
Austria
Prior art keywords
butyrospermum parkii
extracts
composition containing
medicinal product
extract
Prior art date
Application number
AT00943697T
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Bsp Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27512830&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE239490(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bsp Pharma As filed Critical Bsp Pharma As
Application granted granted Critical
Publication of ATE239490T1 publication Critical patent/ATE239490T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT00943697T 1999-07-09 2000-07-10 Zusammensetzung enthaltend butyrospermum parkii extrakte und die verwendung als arzneimittel oder nahrungszusatz ATE239490T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DKPA199901003 1999-07-09
DKPA199901323 1999-09-16
US15465199P 1999-09-20 1999-09-20
DKPA200000434 2000-03-16
US19091900P 2000-03-21 2000-03-21
PCT/DK2000/000383 WO2001003712A1 (en) 1999-07-09 2000-07-10 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement

Publications (1)

Publication Number Publication Date
ATE239490T1 true ATE239490T1 (de) 2003-05-15

Family

ID=27512830

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00943697T ATE239490T1 (de) 1999-07-09 2000-07-10 Zusammensetzung enthaltend butyrospermum parkii extrakte und die verwendung als arzneimittel oder nahrungszusatz

Country Status (14)

Country Link
US (3) US20050031709A1 (de)
EP (2) EP1200106B2 (de)
JP (1) JP2003504340A (de)
CN (1) CN1367699A (de)
AT (1) ATE239490T1 (de)
AU (1) AU784718B2 (de)
CA (1) CA2378396C (de)
DE (1) DE60002581T2 (de)
DK (1) DK1200106T3 (de)
ES (1) ES2198324T3 (de)
HK (1) HK1046502B (de)
NZ (1) NZ517077A (de)
PT (1) PT1200106E (de)
WO (1) WO2001003712A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1001007T3 (da) 1998-11-13 2008-07-07 Loders Croklaan Bv Sterolkoncentrater , anvendelse og fremstilling deraf
JP2003002835A (ja) * 2001-06-21 2003-01-08 Unitika Ltd 機能性食品
DE60214509T2 (de) * 2001-01-12 2007-05-31 Bsp Pharma A/S Dihydrotriterpene bei der Behandlung von viralen Infektionen, Herz-Kreislauf-Erkrankungen, Entzündungen, Üüberempfindlichkeit oder Schmerzen
JP4542300B2 (ja) * 2002-02-15 2010-09-08 株式会社ファンケル ヒアルロン酸蓄積促進剤
EP1424073A1 (de) * 2002-11-27 2004-06-02 Loders Croklaan B.V. Antidiarrhöe - Zusammensetzungen
US7070815B2 (en) 2002-11-27 2006-07-04 Loders Croklaan Usa Llc Anti diarrhoea compositions
FR2859103B1 (fr) * 2003-09-02 2005-11-25 Silab Sa Procede d'obtention d'un principe actif detoxifiant pour la peau, principe actif obtenu
US20060003948A1 (en) * 2004-02-06 2006-01-05 Krasutsky Pavel A Compositions that include a triterpene and a carrier
DE102004030044A1 (de) 2004-06-22 2006-01-12 Birken Gmbh Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
FR2885527B1 (fr) * 2005-05-16 2007-06-29 Galderma Res & Dev Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise
CH704033B1 (de) * 2007-03-26 2012-05-15 Swiss Caps Rechte Und Lizenzen Ag Kapseln enthaltend Pflanzenzubereitungen.
JP5428000B2 (ja) * 2007-06-27 2014-02-26 株式会社スカイライト・バイオテック ルペオール含有医薬組成物、食品及び飼料
WO2010104375A1 (en) * 2009-03-12 2010-09-16 N.V. Nutricia Stigmasterol for the treatment of alzheimer's disease
FR2984748B1 (fr) * 2011-12-26 2017-02-10 Expanscience Lab Utilisation d'avocats mous entiers pour obtenir une huile d'avocat riche en insaponifiable
EP2784114B1 (de) 2013-03-26 2016-01-13 Sociedad Anónima Minera Catalano-Aragonesa Biologisch basiertes und biologisch abbaubares Polymer
KR102409140B1 (ko) * 2016-04-13 2022-06-14 에이에이케이 아베 (파블) 무취 시어-기반 에스테르
IT201600093764A1 (it) * 2016-09-19 2018-03-19 Codex V Srl Insaponificabili di lipidi naturali per l’uso nel trattamento di patologie reumatiche
EP3735274A1 (de) 2018-01-04 2020-11-11 Amryt Research Limited Betulinhaltige birkenrindenextrakte und ihre formulierung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB932662A (en) * 1960-04-13 1963-07-31 Laroche Navarron Lab Therapeutic compositions comprising butyrospermol
LU85130A1 (fr) * 1983-12-12 1985-09-12 Oreal Composition cosmetique aqueuse ou anhydre contenant une phase grasse a base d'huile de karite
US5262872A (en) * 1985-03-28 1993-11-16 Canon Kabushiki Kaisha Image forming apparatus with means for error detection
US5626872A (en) * 1992-06-16 1997-05-06 Roemmers S.A.I.C.F. Pharmaceutical soft capsules containing lysine clonixinate and a process for their preparation
FR2702773B1 (fr) † 1993-03-19 1995-06-16 Deslog Procede de preparation de fractions de matieres grasses d'origine vegetale enrichies en matieres insaponifiables.
DE4426148A1 (de) † 1994-07-22 1996-01-25 Henkel Kgaa Kosmetische und/oder pharmazeutische Zubereitungen
GB9515214D0 (en) * 1995-07-25 1995-09-20 Univ Strathclyde Plant extracts
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
DE69722210T2 (de) † 1996-07-05 2004-04-01 Unilever N.V. Verfahren zur herstellung einer mischung von sterin-estern
FR2770400B1 (fr) * 1997-10-30 1999-12-03 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait vegetal obtenu a partir de la fleur de l'arbre a karite ou butyrospermum parkii kotschy
US6190170B1 (en) * 1998-05-05 2001-02-20 Dentech, Llc Automated tooth shade analysis and matching system
SE514725C2 (sv) † 1998-06-02 2001-04-09 Karlshamns Ab Fraktioneringsförfarande

Also Published As

Publication number Publication date
EP1200106B2 (de) 2010-08-11
EP1200106B1 (de) 2003-05-07
CA2378396A1 (en) 2001-01-18
WO2001003712A1 (en) 2001-01-18
HK1046502A1 (en) 2003-01-17
ES2198324T3 (es) 2004-02-01
JP2003504340A (ja) 2003-02-04
EP1354595A1 (de) 2003-10-22
US20080124413A1 (en) 2008-05-29
NZ517077A (en) 2003-11-28
AU5806600A (en) 2001-01-30
AU784718B2 (en) 2006-06-01
CA2378396C (en) 2010-12-21
DK1200106T3 (da) 2003-10-27
US20070003645A1 (en) 2007-01-04
CN1367699A (zh) 2002-09-04
HK1046502B (en) 2003-09-19
DE60002581T2 (de) 2004-03-25
DE60002581D1 (de) 2003-06-12
US20050031709A1 (en) 2005-02-10
PT1200106E (pt) 2003-09-30
EP1200106A1 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
ATE239490T1 (de) Zusammensetzung enthaltend butyrospermum parkii extrakte und die verwendung als arzneimittel oder nahrungszusatz
ATE249231T1 (de) Arzneimittel, nahrungszusätze und kosmetische zubereitung enthaltend eine fettsäure und ingwer
Wenzig et al. Phytochemical composition and in vitro pharmacological activity of two rose hip (Rosa canina L.) preparations
KR100755798B1 (ko) 화란국화(타나세텀 파르테니움) 추출물을 포함하는 국소 조성물과, 이 조성물을 사용해서 염증 질환을 치료 및 예방하는 방법
EP4442241A3 (de) Retinolersatz zur hautbehandlung
ES2863561T3 (es) Fitocomplejos de Citrus bergamia
EP0903143A3 (de) Verwendung von Daidzein zur Herstellung eines Arzneimittels zur Erhöhung des HDL Cholesterolniveaus
IL164699A (en) Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient
WO2017094905A1 (ja) 育毛・発毛促進剤
AU2874099A (en) Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof
DE60004797D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
EP0925068A1 (de) Pharmazeutische zusammensetzung die polyphenole, insbesondere resveratrol, und hefeextrakte enthalt
ATE299370T1 (de) Carnitin und inositolphosphat enthaltende zusammensetzung als diätzusatz oder arzneimittel
CA2807520A1 (en) Soybean extracts for the treatment of hepatic disorders
IL158878A0 (en) Pharmaceuticals and cosmetic compositions against skin aging
IL146284A0 (en) Androgen glycosides and pharmaceutical compositions containing the same
WO2002055087B1 (en) Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
WO2000062751A3 (en) Oral care compositions containing boswellia extracts
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
WO2001074780A8 (en) Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
US11147835B1 (en) Nutritional supplement
WO2002072035A3 (en) Novel anti-inflammatory compositions and methods of use
WO2003039437A3 (de) Oral verabreichbare pharmazeutische zubereitung umfassend liposo mal verkapseltes taxol
ZA987436B (en) Method of increasing oral bioavailability of compounds
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1200106

Country of ref document: EP

RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties